Corona, The World’s Most Valuable Beer Brand1, Announces Its 100-Year Anniversary with Global Celebration
25.4.2025 10:00:00 CEST | Business Wire | Press release
Brand Invites The World to Join the Celebration with Experiences at the Most Epic Beaches on EarthGlobal “Corona 100” Platform Launches with a Legendary Concert at Copacabana Beach, Featuring One of the World’s Top Musical Artists with Millions in Attendance
Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/
Corona 100 This Is Living Since 1925
In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive list of the top 100 beaches in the world to visit, and a signed multi-year sponsorship of a renowned concert at Copacabana Beach in Rio de Janeiro — all offering people across the globe opportunities to connect with their beach side.
“For 100 years, Corona has fully embodied the ‘This is Living’ spirit of the beach lifestyle, inspiring people to disconnect from their everyday routine and reconnect with nature and each other,” said Clarissa Pantoja, Global VP of Corona. “Enjoyed by millions around the world today and still growing, Corona will always remain unwavering in its commitment to the beach. This anniversary is not just a celebration of our legacy, but also a call for everyone to embrace their best side – the beach side – both now and for the next 100 years to follow.”
100 Years, 100 Iconic Beaches
To honor a century of beach side living, the brand has created its CoronaBeach 100list: a curated guide of the world’s most iconic beaches that best represent Corona’s “This is Living” expression. From hidden coves to legendary coastlines to remote paradises, these beaches aren’t just destinations; they’re places where people have traveled for centuries to disconnect from the real world and reconnect with nature.
The guide includes sandy beaches from famed hotspots within South Africa, Mexico, and Brazil, as well as showcases some lesser traveled shorelines, such as Chile’s Punta de Lobos, Iceland’s Stokksnes Beach, and Canada’s Cox Bay Beach, among many more.
Additionally, Corona is offering the chance to visit the iconic beaches featured on the Beach 100 list. Anyone of legal drinking age can enter to win a chance to tap into their beach side at one of the 100 crowned coastlines simply by purchasing the special edition 100 Anniversary pack and scanning the QR code. Other instant win items include Corona merchandise, coolers, towels, and digital vouchers.
To build the guide, Corona assembled a panel of beach experts, comprised of oceanographers, surfers, free divers, and other nature enthusiasts to curate the list, all who meticulously rated hundreds of the world’s beaches using a carefully curated set of criteria. Each beach in the Corona Beach 100 is “Sun Awarded” – rated between one to three suns – and recognizes the locations that embody the true spirit of “This is Living” based on three essential elements: Beachside Culture, Connection to Nature, and Scenic Aesthetics.
To access the Beach 100 list – developed in partnership with experiential marketing agency, WINK – and to learn more about how to win Beach 100 prizes, visit Corona.com for more information.
Cheers to 100 Years at Copacabana Beach
To kick-off the anniversary in grand fashion, Corona will take over one of the most iconic beaches in the world – Copacabana Beach in Rio De Janeiro – as a marquee sponsor of a global concert that will transform the shores of Copacabana Beach into the ultimate celebration. Taking place on May 3rd, the concert will captivate millions of attendees on the beach where each year the concert will feature some of the world’s most popular musical artists and bands.
A Century of Beach Culture
From its origins in Mexico in 1925, Corona has been dedicated to quality with an emphasis on how the beach lifestyle positively impacts consumers worldwide. Named the World’s Most Valuable Beer Brand1 in 2024, Corona has turned every sip into a moment of connection through its premium products – brewed with 100% natural ingredients including its iconic lime ritual – and continues to bring more “This is Living” moments of social connection and relaxation into the world.
To highlight those 100 years of beach culture, Corona has unveiled a branded legacy film, titled “This is Living Since 1925," that brings to life many decades unfolding over the course of a day. From the early beginnings of beach side gatherings during the bikini era to swimming and surfing across the globe today, the archival look and feel across the film sets the tone for each decade, which also depicts a variety of beaches and coastlines from around the world.
As seen in the film – created in partnership with Wieden+Kennedy Amsterdam – Corona’s integration within the beach culture is effortless in the scenes over time, a testament to the brand’s natural place on the beach “Since 1925.”
The 360 platform also features vibrant new digital, trade, and OOH assets that highlight how Corona has remained a staple for beach lovers from around the world for generations — no matter the season or location.
The centennial celebrations will continue throughout 2025, so grab a lime, raise a Corona, and join the brand in commemorating a century of vibrant beachside living. Cheers to 100 years under the sun and to the next century of unforgettable "This Is Living" moments.
About Corona Global
Corona, an AB InBev global brand*, is the iconic beer brand that is synonymous with paradise with a presence in 180 countries. Recognized as the world’s most valuable beer brand in Kantar’s BrandZ global 2024 rankings, Corona invites the world outside, beckoning you to reconnect with your essential nature and embrace the simple pleasures of life. But it's not just about the beer – it's about the ritual. The ritual of adding a slice of lime to your Corona, an experience that elevates the moment. Corona isn't just a beverage; it's nature in a bottle. And we strive to help protect nature and have become the first global beverage brand with a net-zero plastic footprint. This builds on our longstanding ambition to help protect the world’s oceans and beaches from plastic pollution. Every sip of Corona is a celebration of nature and the beauty of the world around us.
*Corona is not sold by AB InBev in the United States.
About AB InBev
Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 144 000 colleagues based in nearly 50 countries worldwide. For 2024, AB InBev’s reported revenue was 59.8 billion USD (excluding JVs and associates).
1Kantar BrandZ 2024 Global Rankings |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250425804516/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release
Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 20:30:00 CEST | Press release
The winner was announced on the Kappa FuturFestival stage, following the performances of the five finalists selected by the international jury.German duo PARAFRAME & Avis Vox received the special Reply AI Studios Grand Prix award. The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stag
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 15:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 15:00:00 CEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom